ELEV - Wall Street Estimates - Elevation Oncology, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.4974

-5.06 %

$ 29.4 M

Market Cap

-0.62

P/E

Price Target Average

1709.41%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

18.60%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Elevation Oncology, Inc.

Wall Street analysts predict an average 1-year price target for ELEV of $9 , with forecasts ranging from a low of $8 to a high of $10 .

ELEV Lowest Price Target Wall Street Target

8 USD 1508.36%

ELEV Average Price Target Wall Street Target

9 USD 1709.41%

ELEV Highest Price Target Wall Street Target

10 USD 1910.45%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free